157 related articles for article (PubMed ID: 19740546)
1. Olanzapine vs. lithium in management of acute mania.
Shafti SS
J Affect Disord; 2010 May; 122(3):273-6. PubMed ID: 19740546
[TBL] [Abstract][Full Text] [Related]
2. [Antipsychotics in bipolar disorders].
Vacheron-Trystram MN; Braitman A; Cheref S; Auffray L
Encephale; 2004; 30(5):417-24. PubMed ID: 15627046
[TBL] [Abstract][Full Text] [Related]
3. Olanzapine versus lithium in the acute treatment of bipolar mania: a double-blind, randomized, controlled trial.
Niufan G; Tohen M; Qiuqing A; Fude Y; Pope E; McElroy H; Ming L; Gaohua W; Xinbao Z; Huichun L; Liang S
J Affect Disord; 2008 Jan; 105(1-3):101-8. PubMed ID: 17531327
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of olanzapine in combination with valproate or lithium in the treatment of mania in patients partially nonresponsive to valproate or lithium monotherapy.
Tohen M; Chengappa KN; Suppes T; Zarate CA; Calabrese JR; Bowden CL; Sachs GS; Kupfer DJ; Baker RW; Risser RC; Keeter EL; Feldman PD; Tollefson GD; Breier A
Arch Gen Psychiatry; 2002 Jan; 59(1):62-9. PubMed ID: 11779284
[TBL] [Abstract][Full Text] [Related]
5. Initial symptoms of manic relapse in manic or mixed-manic bipolar disorder: post hoc analysis of patients treated with olanzapine or lithium.
Houston JP; Lipkovich IA; Ahl J; Rotelli MD; Baker RW; Bowden CL
J Psychiatr Res; 2007 Oct; 41(7):616-21. PubMed ID: 16236320
[TBL] [Abstract][Full Text] [Related]
6. Olanzapine compared to lithium in mania: a double-blind randomized controlled trial.
Berk M; Ichim L; Brook S
Int Clin Psychopharmacol; 1999 Nov; 14(6):339-43. PubMed ID: 10565800
[TBL] [Abstract][Full Text] [Related]
7. Variables as mediators or moderators in predicting relapse to any type of mood episode in a bipolar maintenance study.
Tohen M; Wang WV; Leboyer M; Jen KY
J Clin Psychiatry; 2012 Jul; 73(7):e913-7. PubMed ID: 22901362
[TBL] [Abstract][Full Text] [Related]
8. Olanzapine-divalproex combination versus divalproex monotherapy in the treatment of bipolar mixed episodes: a double-blind, placebo-controlled study.
Houston JP; Tohen M; Degenhardt EK; Jamal HH; Liu LL; Ketter TA
J Clin Psychiatry; 2009 Nov; 70(11):1540-7. PubMed ID: 19778495
[TBL] [Abstract][Full Text] [Related]
9. Analyses of treatment-emergent mania with olanzapine/fluoxetine combination in the treatment of bipolar depression.
Keck PE; Corya SA; Altshuler LL; Ketter TA; McElroy SL; Case M; Briggs SD; Tohen M
J Clin Psychiatry; 2005 May; 66(5):611-6. PubMed ID: 15889948
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of olanzapine combined with valproate or lithium in the treatment of dysphoric mania.
Baker RW; Brown E; Akiskal HS; Calabrese JR; Ketter TA; Schuh LM; Trzepacz PT; Watkin JG; Tohen M
Br J Psychiatry; 2004 Dec; 185():472-8. PubMed ID: 15572737
[TBL] [Abstract][Full Text] [Related]
11. Safety and efficacy of olanzapine monotherapy and olanzapine with a mood stabilizer in 18-week treatment of manic/mixed episodes for Japanese patients with bipolar I disorder.
Katagiri H; Takita Y; Tohen M; Higuchi T; Kanba S; Takahashi M
Curr Med Res Opin; 2012 May; 28(5):701-13. PubMed ID: 22356118
[TBL] [Abstract][Full Text] [Related]
12. Impact of obsessive-compulsive disorder on the antimanic response to olanzapine therapy in youth with bipolar disorder.
Joshi G; Mick E; Wozniak J; Geller D; Park J; Strauss S; Biederman J
Bipolar Disord; 2010 Mar; 12(2):196-204. PubMed ID: 20402712
[TBL] [Abstract][Full Text] [Related]
13. The impact of response to previous mood stabilizer therapy on response to olanzapine versus placebo for acute mania.
Baker RW; Goldberg JF; Tohen M; Milton DR; Stauffer VL; Schuh LM
Bipolar Disord; 2002 Feb; 4(1):43-9. PubMed ID: 12047494
[TBL] [Abstract][Full Text] [Related]
14. Long-term olanzapine therapy in the treatment of bipolar I disorder: an open-label continuation phase study.
Sanger TM; Grundy SL; Gibson PJ; Namjoshi MA; Greaney MG; Tohen MF
J Clin Psychiatry; 2001 Apr; 62(4):273-81. PubMed ID: 11379842
[TBL] [Abstract][Full Text] [Related]
15. Olanzapine monotherapy and olanzapine combination therapy in the treatment of mania: 12-week results from the European Mania in Bipolar Longitudinal Evaluation of Medication (EMBLEM) observational study.
Vieta E; Panicali F; Goetz I; Reed C; Comes M; Tohen M;
J Affect Disord; 2008 Feb; 106(1-2):63-72. PubMed ID: 17582508
[TBL] [Abstract][Full Text] [Related]
16. Post-acute effectiveness of lithium in pediatric bipolar I disorder.
Findling RL; Kafantaris V; Pavuluri M; McNamara NK; Frazier JA; Sikich L; Kowatch R; Rowles BM; Clemons TE; Taylor-Zapata P
J Child Adolesc Psychopharmacol; 2013 Mar; 23(2):80-90. PubMed ID: 23510444
[TBL] [Abstract][Full Text] [Related]
17. Valproate or olanzapine add-on to lithium: an 8-week, randomized, open-label study in Italian patients with a manic relapse.
Maina G; Albert U; Salvi V; Mancini M; Bogetto F
J Affect Disord; 2007 Apr; 99(1-3):247-51. PubMed ID: 17056122
[TBL] [Abstract][Full Text] [Related]
18. Olanzapine: a review of its use in the treatment of bipolar I disorder.
Bhana N; Perry CM
CNS Drugs; 2001; 15(11):871-904. PubMed ID: 11700151
[TBL] [Abstract][Full Text] [Related]
19. Melatonin for Reducing Weight Gain Following Administration of Atypical Antipsychotic Olanzapine for Adolescents with Bipolar Disorder: A Randomized, Double-Blind, Placebo-Controlled Trial.
Mostafavi SA; Solhi M; Mohammadi MR; Akhondzadeh S
J Child Adolesc Psychopharmacol; 2017 Jun; 27(5):440-444. PubMed ID: 28339282
[TBL] [Abstract][Full Text] [Related]
20. Adjunctive oral ziprasidone in patients with acute mania treated with lithium or divalproex, part 1: results of a randomized, double-blind, placebo-controlled trial.
Sachs GS; Vanderburg DG; Karayal ON; Kolluri S; Bachinsky M; Cavus I
J Clin Psychiatry; 2012 Nov; 73(11):1412-9. PubMed ID: 23218157
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
